Your Top 100 most-cited badge
A badge for your website, a sentence for your CV, and a permanent page where anyone can check the rank.
The article
IMpower110: Interim overall survival (OS) analysis of a phase III study of atezolizumab (atezo) vs platinum-based chemotherapy (chemo) as first-line (1L) treatment (tx) in PD-L1–selected NSCLC
David Robert Spigel, Filippo de Marinis, Giuseppe Giaccone, Niels Reinmuth, Alain Vergnenégre, C.H. Barrios and 14 more
- Rank
- 85 of 4,622
- Percentile
- top 1.9%
- Where
- Annals of Oncology, 2019
- Citations
- 146
From the 2019 list, OpenAlex counts as of 2026-10-29.
Prefer not to be listed? The same link lets you withhold your name on every list; the article stays, your name does not. Questions: team@avidnote.com.